Allergan (NYSE: AGN), the maker of BOTOX® (Botulininum Toxin Type A) and the Juvéderm™ family of dermal fillers, today announced the availability of its 'next-generation' hyaluronic acid (HA) dermal filler formulation, Juvéderm™ VOLUMA™ in India. Juvéderm™ VOLUMA™ is an advanced HA formulation that provides facial volume lasting up to 18 months1.
Juvéderm™ VOLUMA™ was developed to be smooth in consistency, making it easier to inject and can be used in a variety of sub-dermal and deep dermal indications. The results are immediate, long-lasting and natural in appearance. Juvéderm™ VOLUMA™ helps restore youthful volume by enhancing cheeks, cheekbones and chin that have become hollow or thin due to weight loss or age-related facial fat loss1.
Noted TV presenter, actor and one of India’s most vivacious beauties, Mandira Bedi, launched the product here, in the presence of the country’s well known Aesthetic consultants, Dr. Jamuna Pai, Dr. Sangeeta Amladi, Dr. Vandana Chatrath, Dr. Chiranjiv Chhabra, Dr. Simal Soin and Mr. Raghu Kumar, Managing Director, Allergan India.
During the launch, Dr. Jamuna Pai, Cosmetologist, BLUSH, said “As the skin ages and loses volume, facial wrinkles and folds form. Juvéderm™ VOLUMA™ offers revolumisation of facial hollows and recontouring of cheeks and cheekbones for a fuller and softer appearance. Juvéderm™ VOLUMA™ can help restore the balance of the face, making a person look younger and in time, feel more confident.”
“The key ingredient in the Juvéderm™ dermal filler range is hyaluronic acid which is a naturally occurring, biodegradable complex sugar found in the human body. Juvéderm™, a unique smooth consistency malleable gel, flows easily into the skin and creates a smooth, natural look and feel. As a result, we have received positive feedback from patients who have opted for Juvéderm™ Ultra & Ultra Plus,” said Dr. Vandana Chatrath, Cosmetic Physician.
Speaking during the occasion, Mandira Bedi said “Feeling good is about looking good. Today we are not only more aware of our physical appearance; we are also empowered to help ourselves. Products like Juvéderm™ provide non-surgical options to look the way we want to.”
Dermal fillers are used widely in aesthetic clinics to enhance facial aesthetics by addressing folds and wrinkles that develop as men and women age, predominantly in their mid-thirties and forties. Loss in volume and in the skin’s elasticity and lubrication as one ages also cause the sinking of skin under-the-eyes, the hollowing of cheeks and loss of suppleness of the lips. Dermal fillers administered by physicians specialized in aesthetic medicine target these areas by adding (“filling”) volume.
More From This Section
Mr. Raghu Kumar, Managing Director, Allergan Healthcare India said “The launch of Juvéderm™ VOLUMA™ reflects our global leadership in medical aesthetics by extending our next-generation dermal filler portfolio to physicians and patients in India so they have more options to choose from and can tailor treatment to each patient’s desired results. Our ongoing commitment to physician training also helps ensure optimal treatment results and high patient satisfaction.”
Allergan is launching Juvéderm™ VOLUMA™ in India via a series of comprehensive, hands-on training sessions for physicians. Juvéderm™ VOLUMA™ will be available as physician-administered medical aesthetic treatments in leading aesthetic clinics across India.
About the JUVÉDERM™ family of products:
Allergan's Juvéderm™ dermal filler product line includes Juvéderm™ Ultra, Juvéderm™ Ultra Plus and now, Juvéderm™ VOLUMA™, in India, providing physicians with the flexibility to tailor each treatment to the particular needs of the patient.
About Allergan
Allergan, Inc. is a multi-specialty health care company focused on discovering, developing and commercializing innovative pharmaceuticals, biologics and medical devices that enable people to live life to its greatest potential — to see more clearly, move more freely, express themselves more fully.
The Company employs more than 8,300 people worldwide and operates world-class research and development facilities and state-of-the-art manufacturing plants. In addition to its discovery-to-development research programs, Allergan has global marketing and sales capabilities, with a presence in more than 100 countries.